Encevac TC-4 with Havlogen (Canada)

This page contains information on Encevac TC-4 with Havlogen for veterinary use.
The information provided typically includes the following:
  • Encevac TC-4 with Havlogen Indications
  • Warnings and cautions for Encevac TC-4 with Havlogen
  • Direction and dosage information for Encevac TC-4 with Havlogen

Encevac TC-4 with Havlogen

This treatment applies to the following species:
Manufacturer: Merck Animal Health

Equine Vaccine

ENCEPHALOMYELITIS - INFLUENZA VACCINE

EASTERN & WESTERN, KILLED VIRUS

TETANUS TOXOID

Description

A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin, Eastern and Western Equine Encephalomyelitis Viruses, Equine Influenza Virus subtype A2 including KY93, KY02, and NM2/93 strains and Tetanus Toxoid. Intervet serological data suggest cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89, and South Africa 03.

Encevac TC-4 with Havlogen Indications

For vaccination of healthy horses, 6 months of age or older, as an aid in the prevention of disease caused by Eastern and Western Encephalomyelitis Viruses and Tetanus, and as an aid in the reduction of the virus shedding and control of respiratory disease caused by Equine Influenza Virus. Duration of Immunity has been shown to be at least 6 months for Equine Influenza Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

Dosage and Administration

For primary immunization aseptically inject 1 mL intramuscularly. Repeat the dose in 3 to 4 weeks. A 1 mL dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.

CAUTIONS: Store at 2° to 7°C (35° to 45°F). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Injury should be followed by a booster dose of a vaccine containing Tetanus Toxoid. Consult your veterinarian regarding indications and precautions for use of Tetanus Antitoxin. Anaphylactoid reactions may occur.

WARNING: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.

ANTIDOTE: Epinephrine. Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.

FOR USE IN ANIMALS ONLY

*Adjuvant-Intervet’s proprietary technology.

Manufactured by Intervet Inc., Omaha, Nebraska 68103, U.S.A.

U.S. Vet. License No. 165A

For: Intervet Canada Corp., 16750, route Transcanadienne, Kirkland QC, H9H 4M7

For technical enquiries, call toll free 1 888 306-0069.

™ Trademark of Intervet, Inc., used under license by Intervet Canada Corp.

 

 

Code

 

10 Doses

Ten 1 mL Syringes with Separate Sterile Needles

035127

71-413931

10 Doses

10 mL

031685

71-413931

NAC No.: 12081382

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
Every effort has been made to ensure the accuracy of the Encevac TC-4 with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-12-03

(web2)